| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advancing the field of drug delivery
|
Moses, Marsha A
|
|
2003
|
4 |
5 |
p. 337-341
5 p.
|
article
|
| 2 |
Homeobox genes and cancer
|
Abate-Shen, Cory
|
|
2003
|
4 |
5 |
p. 329-330
2 p.
|
article
|
| 3 |
Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements
|
Primiano, Thomas
|
|
2003
|
4 |
5 |
p. 415-
1 p.
|
article
|
| 4 |
Modeling transformation and metastasis in Drosophila
|
Tapon, Nicolas
|
|
2003
|
4 |
5 |
p. 333-335
3 p.
|
article
|
| 5 |
Oct-3/4 is a dose-dependent oncogenic fate determinant
|
Gidekel, Sharon
|
|
2003
|
4 |
5 |
p. 361-370
10 p.
|
article
|
| 6 |
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
|
Chipuk, Jerry E.
|
|
2003
|
4 |
5 |
p. 371-381
11 p.
|
article
|
| 7 |
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
|
Hoffman, Jason A.
|
|
2003
|
4 |
5 |
p. 383-391
9 p.
|
article
|
| 8 |
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis
|
Joyce, Johanna A
|
|
2003
|
4 |
5 |
p. 393-403
11 p.
|
article
|
| 9 |
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas
|
Chen, Jindong
|
|
2003
|
4 |
5 |
p. 405-413
9 p.
|
article
|
| 10 |
Tumor vasculature address book
|
Rafii, Shahin
|
|
2003
|
4 |
5 |
p. 331-333
3 p.
|
article
|
| 11 |
Will mTOR inhibitors make it as cancer drugs?
|
Sawyers, Charles L
|
|
2003
|
4 |
5 |
p. 343-348
6 p.
|
article
|
| 12 |
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue
|
Liang, Huiling
|
|
2003
|
4 |
5 |
p. 349-360
12 p.
|
article
|
Journal description